Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FB.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
FL.18.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FL.18.1.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
FL.26NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FL.26SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
EG.8NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
EG.8SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
FL.32NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FL.32SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
FL.26.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FL.26.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
EG.6NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-4388.79US
EG.6SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
FK.1.3.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26650.4US
FK.1.3.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
FK.1.2.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26650.4US
FK.1.2.2SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
FK.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26650.4US
FK.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
CH.1.1.18NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
CH.1.1.18SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
XBB.1.5.9NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.5.9SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BY.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BQ.1.1.26NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BQ.1.1.26SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BQ.1.1.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BQ.1.1.2SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
XBB.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
XBB.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.3SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BQ.1.1.76NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BQ.1.1.76SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BN.4NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BN.4SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
CK.1.4NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
CK.1.4SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BQ.1.1.11NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BQ.1.1.11SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BA.4.6.4NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.4.6.4SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BQ.1.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BQ.1.3SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BQ.1.5NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BQ.1.5SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BA.2.75.5NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.2.75.5SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BF.7.8NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BF.7.8SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used